Cargando…
High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer
Recent studies have reported that tumor‐infiltrating mast cells (TIM) play an important role in tumor regression, but the effect of TIM in gallbladder cancer (GBC) remains unclear. The present study aims to investigate the prognostic value of TIM in GBC patients and its responsiveness to gemcitabine...
Autores principales: | Bo, Xiaobo, Wang, Jie, Wang, Changcheng, Nan, Lingxi, Gao, Zhihui, Xin, Yanlei, Li, Min, Shen, Sheng, Liu, Han, Ni, Xiaoling, Suo, Tao, Zhang, Dexiang, Lu, Pinxiang, Wang, Yueqi, Liu, Houbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060478/ https://www.ncbi.nlm.nih.gov/pubmed/31925976 http://dx.doi.org/10.1111/cas.14302 |
Ejemplares similares
-
Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer
por: Wang, Jie, et al.
Publicado: (2019) -
Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010‐2016
por: Wang, Jie, et al.
Publicado: (2019) -
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
por: Bo, Xiaobo, et al.
Publicado: (2018) -
ARID1A Downregulation Predicts High PD-L1 Expression and Worse Clinical Outcome in Patients With Gallbladder Cancer
por: Nan, Lingxi, et al.
Publicado: (2022) -
Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma
por: Bo, Xiaobo, et al.
Publicado: (2017)